LORIA, Paola
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 25.842
AS - Asia 11.695
EU - Europa 9.840
SA - Sud America 1.378
AF - Africa 215
Continente sconosciuto - Info sul continente non disponibili 164
OC - Oceania 27
Totale 49.161
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 25.494
SG - Singapore 3.582
CN - Cina 3.365
GB - Regno Unito 3.142
IT - Italia 1.658
HK - Hong Kong 1.493
BR - Brasile 1.029
DE - Germania 991
VN - Vietnam 983
SE - Svezia 964
FI - Finlandia 746
UA - Ucraina 571
BD - Bangladesh 545
TR - Turchia 531
FR - Francia 402
RU - Federazione Russa 392
PL - Polonia 372
KR - Corea 306
BG - Bulgaria 213
IN - India 211
CA - Canada 154
AR - Argentina 123
MX - Messico 97
IQ - Iraq 87
NL - Olanda 82
ID - Indonesia 81
JP - Giappone 81
PK - Pakistan 53
ZA - Sudafrica 52
ES - Italia 48
VE - Venezuela 48
AE - Emirati Arabi Uniti 46
EC - Ecuador 45
MY - Malesia 40
BE - Belgio 36
CO - Colombia 34
PH - Filippine 33
MA - Marocco 32
TW - Taiwan 32
UZ - Uzbekistan 32
CL - Cile 31
AT - Austria 30
LT - Lituania 26
SA - Arabia Saudita 25
EG - Egitto 24
IE - Irlanda 24
JO - Giordania 23
PY - Paraguay 23
CZ - Repubblica Ceca 22
CR - Costa Rica 21
GR - Grecia 20
RO - Romania 19
AU - Australia 17
BO - Bolivia 16
JM - Giamaica 16
NP - Nepal 16
PE - Perù 16
DZ - Algeria 15
IR - Iran 15
TH - Thailandia 15
AZ - Azerbaigian 14
KE - Kenya 14
ET - Etiopia 13
OM - Oman 13
SC - Seychelles 12
TN - Tunisia 12
CH - Svizzera 11
HN - Honduras 11
IL - Israele 11
NI - Nicaragua 11
NG - Nigeria 10
UY - Uruguay 10
AL - Albania 9
BY - Bielorussia 9
DO - Repubblica Dominicana 9
KZ - Kazakistan 9
SI - Slovenia 9
RS - Serbia 8
EU - Europa 7
NZ - Nuova Zelanda 7
GE - Georgia 6
LB - Libano 6
PA - Panama 6
SN - Senegal 6
BA - Bosnia-Erzegovina 5
GT - Guatemala 5
HU - Ungheria 5
QA - Qatar 5
SK - Slovacchia (Repubblica Slovacca) 5
SV - El Salvador 5
UG - Uganda 5
AM - Armenia 4
AO - Angola 4
BB - Barbados 4
BH - Bahrain 4
CY - Cipro 4
KG - Kirghizistan 4
NO - Norvegia 4
PT - Portogallo 4
BF - Burkina Faso 3
Totale 48.943
Salva come PNG Salva come JPEG
Città #
Singapore 2.437
Ashburn 2.231
Fairfield 2.192
Santa Clara 2.090
Southend 2.017
Woodbridge 1.602
Hong Kong 1.476
Houston 1.302
Jacksonville 1.231
Chandler 1.197
Hefei 1.151
San Jose 1.054
Seattle 846
Wilmington 804
Dearborn 796
Ann Arbor 776
Cambridge 722
Beijing 613
Chicago 586
Nyköping 546
London 521
Helsinki 508
Los Angeles 495
Council Bluffs 484
Warsaw 359
Ho Chi Minh City 310
Modena 307
The Dalles 307
New York 302
Seoul 289
Izmir 285
Hanoi 237
San Diego 237
Princeton 221
Sofia 207
Salt Lake City 206
Eugene 201
Milan 173
Des Moines 171
Boardman 170
Lauterbourg 167
Buffalo 143
Munich 139
Shanghai 135
Tampa 132
Dallas 129
Columbus 127
Moscow 124
Grafing 101
São Paulo 98
Elk Grove Village 95
Rome 94
Falls Church 86
Orem 79
Bremen 58
Sterling 57
Phoenix 54
Guangzhou 53
Tokyo 53
Kunming 48
Da Nang 47
Frankfurt am Main 45
Istanbul 44
Jakarta 43
Baghdad 41
Lancaster 40
Bologna 39
Redwood City 39
Montreal 38
Rio de Janeiro 38
Turku 38
Haiphong 37
Brooklyn 36
Mexico City 36
Miami 35
Norwalk 35
Detroit 34
San Mateo 34
Atlanta 33
Fremont 32
Manchester 32
Kent 31
Naples 31
North Bergen 31
Toronto 31
Amsterdam 30
Brussels 29
Chennai 29
Denver 29
San Francisco 29
Washington 27
Bari 26
Dulles 26
Falkenstein 25
Tashkent 25
Johannesburg 24
Verona 24
Biên Hòa 23
Kilburn 23
Miano 23
Totale 34.943
Salva come PNG Salva come JPEG
Nome #
ABCB4 and ABCB11 mutations in intrahepatic cholestasis of pregnancy in an Italian population 726
Increased appearance rate of 27-hydroxycholesterol in vivo in hypercholesterolemia: A possible compensatory mechanism. 460
Neoangiogenesis-related genes are hallmarks of fast-growing hepatocellular carcinomas and worst survival. Results from a prospective study 447
Differential effect of oleic and palmitic acid on lipid accumulation and apoptosis in cultured hepatocytes 443
Effect of liver cirrhosis on the systemic availability of naltrexone in humans 439
Nonalcoholic Fatty Liver Disease in HIV-Infected Patients Referred to a Metabolic Clinic: Prevalence, Characteristics, and Predictors 428
Gender, fatty liver and GGT 422
Review article: diabetes, genetics and ethnicity 419
Decreased hepatic expression of PPAR-gamma coactivator-1 in cholesterol cholelithiasis. 412
Human Immunodeficiency Virus Is the Major Determinant of Steatosis and Hepatitis C Virus of Insulin Resistance in Virus-associated Fatty Liver Disease. 400
Review article: the metabolic syndrome and non-alcoholic fatty liver disease 390
Suppression of bile acid synthesis, but not of hepatic cholesterol 7alpha-hydroxylase expression, by obstructive cholestasis in humans 376
Genetic determinants of susceptibility and severity in nonalcoholic fatty liver disease. 375
Prophylaxis of venous thromboembolism in elderly patients with multimorbidity 373
Is nonalcoholic steatohepatitis associated with a high-though-normal thyroid stimulating hormone level and lower cholesterol levels? 370
Age-associated alterations in cholesterol homeostasis: evidence from a cross-sectional study in a Northern Italy population. 368
Adherence to antibiotic treatment guidelines and outcomes in the hospitalized elderly with different types of pneumonia 364
Herpesvirus DNA is frequently detected in liver tissue from hepatitis C patients 356
Correlation between plasma levels of 7alpha-hydroxy-4-cholesten-3-one and cholesterol 7alpha-hydroxylation rates in vivo in hyperlipidemic patients 347
Effects of bile duct ligation and cholic acid treatment on fatty liver in two rat models of non-alcoholic fatty liver disease 346
Endocrine and liver interaction: the role of endocrine pathways in NASH 344
Non-organ-specific autoantibodies in nonalcoholic fatty liver disease: Prevalence and correlates 340
Classical and innovative insulin sensitizing drugs for the prevention and treatment of NAFLD 334
Hepatitis C virus-infected patients are 'spared' from the metabolic syndrome but not from insulin resistance. A comparative study of nonalcoholic fatty liver disease and hepatitis C virus-related steatosis 333
Practice guidelines for the diagnosis and management of nonalcoholic fatty liver disease. A decalogue from the Italian Association for the Study of the Liver (AISF) Expert Committee. 332
In Vivo Degradation of Cholesterol to Bile Acids Is Reduced in Patients Receiving Parenteral Nutrition. 331
Nonalcoholic fatty liver disease and aging: epidemiology to management 328
Genetic polymorphisms in non-alcoholic fatty liver disease: Interleukin-6-174G/C polymorphism is associated with non-alcoholic steatohepatitis 326
Statins in liver disease: a molehill, an iceberg, or neither? 325
Short-term effects of simvastatin on bile acid synthesis and biliary lipid secretion in human subjects. 322
'True' antimitochondrial antibody-negative primary biliary cirrhosis, low sensitivity of the routine assays, or both? 321
Comparative cytotoxic and cytoprotective effects of taurohyodeoxycholic acid (THDCA) and tauroursodeoxycholic acid (TUDCA) in HepG2 cell line. 319
Cardiovascular risk, lipidemic phenotype and steatosis. A comparative analysis of cirrhotic and non-cirrhotic liver disease due to varying etiology. 319
Hepatocellular carcinoma in a patient treated with efalizumab for psoriasis. 318
Effect of the selective expansion of cholic acid pool on bile lipid composition: possible mechanism of bile acid induced biliary cholesterol desaturation. 314
Liver and kidney foreign bodies granulomatosis in a patient with malocclusion, bruxism, and worn dental prostheses 313
Nuclear receptors as potential molecular targets in cholesterol accumulation conditions: Insights from evidence on hepatic cholesterol degradation and gallstone disease in humans 312
Regulation of bile acid synthesis in humans: effect of treatment with bile acids, cholestyramine or simvastatin on cholesterol 7 alpha-hydroxylation rates in vivo. 310
If steatosis is the atherosclerosis of the liver, are statins the "aspirin" for steatosis? 305
'Endocrine NAFLD' a hormonocentric perspective of nonalcoholic fatty liver disease pathogenesis 301
Is liver fat detrimental to vessels?: intersections in the pathogenesis of NAFLD and atherosclerosis 300
Relationship of serum fetuin-a levels with coronary atherosclerotic burden and NAFLD in patients undergoing elective coronary angiography. 299
From NAFLD in clinical practice to answers from guidelines. 298
Il pool degli acidi biliari quale regolatore del metabolismo epatico del colesterolo: sintesi degli acidi biliari. 298
Short-term multidisciplinary non-pharmacological intervention is effective in reducing liver fat content assessed non-invasively in patients with nonalcoholic fatty liver disease (NAFLD) 297
Magnetic resonance for quantitative assessment of liver steatosis: a new potential tool to monitor antiretroviral-drug-related toxicities. 293
Chronic hepatitis C virus infection and atherosclerosis: Clinical impact and mechanisms. 293
Is cholangiocarcinoma another complication of insulin resistance: A report of three cases 292
Chicken or egg turned into head or belly 291
Advances in the comprehension of the pathophysiology of bile secretion 291
Diet and gallstones in Italy: the cross-sectional MICOL results. 289
Effects of acute changes of bile acid pool composition on biliary lipid secretion 288
Treatment of atherogenic liver based on the pathogenesis of nonalcoholic Fatty liver disease: a novel approach to reduce cardiovascular risk? 287
Risk for cardiovascular events in an Italian population of patients with type 2 diabetes 285
Hepatic nuclear receptors in human cholelithiasis: A link with insulin resistance? 284
MR techniques in the qualitative analysis of liver steatosis: the potential in the differentiation between steatohepatatis and steatosis 283
Alpha but not beta interferon is useful in chronic active hepatitis due to hepatitis C virus - A prospective, double-blind, randomized study 282
Apolipoprotein synthesis in nonalcoholic steatohepatitis 282
Non-alcoholic fatty liver disease (NAFLD) and cardiovascular disease: An open question 282
Ultrasonographic fatty liver indicator, a novel score which rules out NASH and is correlated with metabolic parameters in NAFLD. 280
Pathogenesis and significance of hepatitis C virus steatosis: An update on survival strategy of a successful pathogen 280
Fasting insulin and uric acid levels but not indices of iron metabolism are independent predictors of non-alcoholic fatty liver disease. A case-control study 278
Natural history of gallstone disease: Expectant management or active treatment? Results from a population-based cohort study. 278
Bile acid feeding and hepatic sterol metabolism: effect of deoxycholic acid. 278
Cardiovascular and systemic risk in nonalcoholic fatty liver disease -Atherosclerosis as a major player in the natural course of NAFLD 277
Effect of ursocholic acid on bile lipid secretion and composition 274
Determinants of bile secretion: effect of bile salt structure on bile flow and biliary cation secretion 274
Anatomia e fisiologia delle vie biliari 273
Review article: hepatic steatosis and insulin resistance 273
Bile acid structure and regulation of biliary protein secretion and composition in man 272
NAFLD AND TYPE 2 DIABETES: A GENETIC OR METABOLIC ISSUE? 271
Effect of taurohyodeoxycholic acid on biliary lipid secretion in humans 268
ESTIMATION OF CARDIOVASCULAR RISK IN TYPE 2 DIABETES 267
Nonalcoholic fatty liver disease induced by leuprorelin acetate 267
MOLECULAR REGULATION OF STEROL METABOLISM BY BILE ACIDS IN CULTURED HUMAN HEPATOCYTES 265
Risk of cardiovascular, cardiac and arrhythmic complications in patients with non-alcoholic fatty liver disease. 263
Hepatitis C and diabetes: the inevitable coincidence? 261
Multiecho MR sequences and high-resolution magic angle spinning (HRMAS)ex-vivo spectroscopy in the qualitative analysis and differentiationbetween steatohepatitis and steatosis 260
Incidence of gallstone disease in Italy: Results from a multicenter, population-based Italian study (the MICOL project) 259
Risk factors for hospital readmission of elderly patients 256
Growth hormone plasma levels in nonalcoholic fatty liver disease 255
Do diabetes and obesity promote hepatic fibrosis in familial heterozygous hypobetalipoproteinemia? 254
Influence of age and sex on serum concentrations of total dimeric activin A 253
The effect of chenodeoxycholic acid (CDCA) on cholesterol absorption. 250
Steatosis and hepatitis C virus: mechanisms and significance for hepatic and extrahepatic disease 250
Intestinal solubilization, absorption, pharmacokinetics and bioavailability of chenodeoxycholic acid. 249
Influence of age on bile acid synthesis: Role of hepatic expression of nuclear receptors 249
The prediction of coronary heart disease mortality as a function of major risk factors in over 30.000 men in the italian RIFLE Pooling Project. A comparison with the MRFIT primary screenees 247
Cholesterol absorption in cirrhosis: the role of total and individual bile acid pool size 247
Clinical physiology of NAFLD: A critical overview of pathogenesis and treatment 246
Heart failure and chronic kidney disease in a registry of internal medicine wards 245
α1-antitrypsin mutations in NAFLD: High prevalence and association with altered iron metabolism but not with liver damage 243
Effect of diabetic autonomic neuropathy on gallbladder kinetics in insulin dependent diabetic patients 243
Bile acid composition and hepatic sterol metabolism in man. The effect of deoxycholic acid administration. 240
Cholesterol metabolism in gallstone disease .Preliminary evidence from the analysis of circulating markers of sterol homeostasis 240
Patogenesi della colelitiasi. I. Colelitiasi colesterinica. 239
Metabolic alterations and chronic hepatitis C: treatment strategies. 239
HEPATIC EXPRESSION OF NUCLEAR RECEPTORS AND BILIARY TRANSPOTERS IN HUMAN CHOLESTEROL GALLSTONE DISEASE. 239
Nonsynonymous mutations within APOB in human familial hypobetalipoproteinemia: evidence for feedback inhibition of lipogenesis and postendoplasmic reticulum degradation of apolipoprotein B. 238
HEPATIC NUCLEAR RECEPTOR EXPRESSION AND REGULATION OF BILE ACID SYNTHESIS IN HUMANS 237
Totale 30.799
Salva come PNG Salva come JPEG
Categoria #
all - tutte 190.287
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 190.287
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20223.532 0 502 394 313 87 156 261 204 392 213 607 403
2022/20233.279 363 354 205 326 401 583 72 310 385 29 142 109
2023/20242.003 84 119 114 136 457 221 216 286 56 42 75 197
2024/20257.463 263 87 129 495 1.607 971 588 413 707 257 838 1.108
2025/202616.044 897 613 1.224 1.896 2.968 1.580 1.933 628 1.369 1.138 992 806
2026/20271.237 389 848 0 0 0 0 0 0 0 0 0 0
Totale 49.161